Funded by the U.S. Centers for Disease Control and Prevention (CDC), this five-year project builds upon activities funded by CDC to support Global Health Security through implementation of programs and activities that focus on protecting and improving health globally through partnerships with Ministries of Health and other institutions. With an initial emphasis on addressing the COVID-19 pandemic, the project is supporting countries—including Burkina Faso—and carrying out regional work in West Africa and South America to improve prevention of avoidable epidemics, including naturally occurring outbreaks and intentional or accidental releases of dangerous pathogens, and to improve ability to detect threats early and respond rapidly and effectively to public health threats of international concern. The project is being implemented by a Jhpiego-led consortium that includes the Johns Hopkins Center for Health Security, the Johns Hopkins University Applied Physics Laboratory, Global Scientific Solutions for Health, and Johns Hopkins University Center for Global Health.

Funded by the Bill & Melinda Gates Foundation, this program promotes access to family planning choices in West African countries by supporting the introduction and scale-up of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC). DMPA-SC is an innovative injectable contraceptive—also known as Sayana® Press—that can dramatically expand access and choice for women. Jhpiego is enhancing ongoing efforts of the Access Collaborative by strengthening health systems to accelerate introduction and scale-up of DMPA-SC in several West African countries. This is being done in Burkina Faso through advocacy on the national, regional and local levels with officials, leaders, providers and clients, sharing of best practices among partners and the creation of a technical working group to work towards administration of DMPA-SC by community health workers and self-injection by patients.

This four-year project, funded by the Bill & Melinda Gates Foundation, builds on the PMA2020 project, which used innovative mobile technology to support low-cost, rapid-turnaround surveys monitoring key health and development indicators. PMA is enhancing this survey platform to generate high-quality data and ensure that governments, donors, managers and advocates use this data to make decisions regarding family planning programs. In addition to scaling up the survey platform for more widespread use, this project supports expanding it to include additional technical areas. Co-led by Jhpiego and the Bill & Melinda Gates Institute for Population and Reproductive Health, this project is operational in several African and Asian countries, including Burkina Faso.

Unitaid is funding a consortium, led by Expertise France, that seeks to eliminate cervical cancer in Burkina Faso, Côte d’Ivoire, Guatemala and the Philippines through secondary prevention (i.e., detecting disease early to slow or halt its progress). The three-year SUCCESS project is designed to shift the countries from a largely opportunistic cervical cancer screening model to a systematic approach centered on innovations related to: 1) reinforced and simplified cervical cancer screening through the introduction of human papilloma virus (HPV) testing with self-collection sampling; 2) secondary prevention of cervical cancer including use of efficient methods for treatment of cervical precancerous lesions such as thermal ablation; and 3) intensified dissemination of information on cervical cancer and new preventive technologies. In so doing, SUCCESS aims to support countries to “leapfrog” to a state-of-the-art services model recommended by the World Health Organization. As the implementing partner of the consortium, Jhpiego is integrating and expanding cervical cancer prevention and treatment services into both new and existing platforms, relying on our established relationships with governments and stakeholders in all four countries. Through demand-generation and community engagement activities, the project plans to screen a total of 185,000 women, a significant proportion of whom will be women living with HIV.

This three-year project, funded by a Large Anonymous Donor through the Ministry of Health, has the objective of improving sexual and reproductive health (SRH) by strengthening the health system in Burkina Faso. Jhpiego and other implementing partners (Pathfinder and EngenderHealth) are providing technical support for the implementation of a coordinated set of project activities in five health regions of the country (Centre, Centre-Est, Centre-Sud, Centre-Ouest and Est). These activities include: 1) build and expand access to high-quality family planning (FP) and abortion services through innovative changes; 2) build the capacity of health facilities to offer high-quality FP, abortion and other SRH services; and 3) strengthen the health information system for FP, abortion and other SRH service provision.

This project, funded by the U.S. Centers for Disease Control and Prevention, seeks to enhance detection and response to infectious disease threats globally by developing networks to implement prevention and containment strategies at local, national and regional levels. Interventions are aimed to prevent, detect and respond to infectious disease threats in healthcare, including antimicrobial resistance, healthcare-associated infections and COVID-19. Jhpiego’s role in this project, which is led by Global Scientific Solutions for Health, is to help facilities in Burkina Faso better respond to threats associated with meningitis.